Literature DB >> 2539297

Radiation sensitivity of human lung cancer cell lines.

J Carmichael1, W G Degraff, J Gamson, D Russo, A F Gazdar, M L Levitt, J D Minna, J B Mitchell.   

Abstract

X-Ray survival curves were determined using a panel of 17 human lung cancer cell lines, with emphasis on non-small cell lung cancer (NSCLC). In contrast to classic small cell lung cancer (SCLC) cell lines, NSCLC cell lines were generally less sensitive to radiation as evidenced by higher radiation survival curve extrapolation numbers, surviving fraction values following a 2 Gy dose (SF2) and the mean inactivation dose values (D) values. The spectrum of in vitro radiation responses observed was similar to that expected in clinical practice, although mesothelioma was unexpectedly sensitive in vitro. Differences in radiosensitivity were best distinguished by comparison of SF2 values. Some NSCLC lines were relatively sensitive, and in view of this demonstrable variability in radiation sensitivity, the SF2 value may be useful for in vitro predictive assay testing of clinical specimens.

Entities:  

Mesh:

Year:  1989        PMID: 2539297     DOI: 10.1016/0277-5379(89)90266-6

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  33 in total

1.  Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.

Authors:  K Liang Zeng; Arjun Sahgal; Zain A Husain; Sten Myrehaug; Chia-Lin Tseng; Jay Detsky; Arman Sarfehnia; Mark Ruschin; Mikki Campbell; Monica Foster; Sunit Das; Nir Lipsman; Georg A Bjarnason; Eshetu G Atenafu; Pejman Jabehdar Maralani; Hany Soliman
Journal:  J Neurooncol       Date:  2021-01-16       Impact factor: 4.130

Review 2.  New challenges in high-energy particle radiobiology.

Authors:  M Durante
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

3.  Long non-coding RNA transcribed from pseudogene PPIAP43 is associated with radiation sensitivity of small cell lung cancer cells.

Authors:  Shilong Wang; Jinming Yu
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

Review 4.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Authors:  Adi F Gazdar; Boning Gao; John D Minna
Journal:  Lung Cancer       Date:  2010-01-15       Impact factor: 5.705

5.  Current therapies for malignant pleural mesothelioma.

Authors:  Takashi Nakano
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

6.  Radiotherapy applications of patients with malignant mesothelioma: A single center experience.

Authors:  Muge Akmansu; Ozge Petek Erpolat; Fatih Goksel; Evrim Tunc; Can Ozturk
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-09

7.  Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel approach.

Authors:  Najmunnisa Nasreen; Nazli Khodayari; Kamal A Mohammed
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

Review 8.  Radiogenomics predicting tumor responses to radiotherapy in lung cancer.

Authors:  Amit K Das; Marcus H Bell; Chaitanya S Nirodi; Michael D Story; John D Minna
Journal:  Semin Radiat Oncol       Date:  2010-07       Impact factor: 5.934

9.  A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma.

Authors:  Stephanie R Rice; Yun R Li; Theresa M Busch; Michele M Kim; Sally McNulty; Andrea Dimofte; Timothy C Zhu; Keith A Cengel; Charles B Simone
Journal:  Photochem Photobiol       Date:  2018-12-28       Impact factor: 3.421

Review 10.  Is there a role for prophylactic radiotherapy to intervention tract sites in patients with malignant pleural mesothelioma?

Authors:  Paul Halford; Amelia O Clive
Journal:  Transl Lung Cancer Res       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.